Date: 2015-04-01
Type of information: Nomination
Compound:
Company: Celgene (USA - NJ)
Therapeutic area: Cancer - Oncology - Inflammatory diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On April 1, 2015, Celgene announced the appointment of Gerald F. Masoudi as Executive Vice President, General Counsel and Corporate Secretary, effective June 1, 2015 . Mr. Masoudi will be responsible for global legal strategy and will serve on the company\'s Executive Committee. Mr. Masoudi will succeed Lawrence V. Stein , Celgene\'s Executive Vice President, General Counsel and Corporate Secretary since 2012, who is retiring from Celgene following a distinguished business and legal career that also included serving as General Counsel for Wyeth and Genetics Institute and as a partner at the law firm Arnold & Porter. Mr. Masoudi joins Celgene from Covington & Burling LLP , a leading international law firm, where he is a partner and serves as co-chair of the Food and Drug practice group. At Covington, he has advised multinational companies and trade associations on significant litigation, enforcement, regulatory and public policy matters. Before joining Covington, Mr. Masoudi served as Chief Counsel of the U.S. Food and Drug Administration . Before joining FDA , Mr. Masoudi served as Deputy Assistant Attorney General for international, policy and appellate matters in the Antitrust Division of the U.S. Department of Justice . Before his government service, Mr. Masoudi was a trial and litigation partner with the law firm Kirkland & Ellis . Immediately following his graduation from law school, he clerked for Judge Frank H . Easterbrook of the U.S. Court of Appeals for the Seventh Circuit. Mr. Masoudi received his J.D. from The University of Chicago Law School , graduating with high honors and serving on the editorial board of the Law Review. He received his B.A. in economics from Amherst College , Phi Beta Kappa.
Financial terms:
Latest news:
